Bleomycin Electrosclerotherapy (BEST) for Slow-Flow Malformations of the Upper Aerodigestive Tract

<b>Background/Objectives:</b> Bleomycin electrosclerotherapy (BEST), which combines intralesional bleomycin administration with electroporation, enhances drug uptake and has shown efficacy in treating vascular malformations resistant to conventional therapies. While BEST is increasingly used in various anatomical sites, its application in the upper aerodigestive tract remains underexplored. This study evaluates the safety and effectiveness of BEST in managing slow-flow vascular malformations of the oral cavity, tongue, larynx, and hypopharynx. <b>Methods:</b> In this retrospective, multicenter study, 20 patients with symptomatic slow-flow vascular malformations of the upper aerodigestive tract were treated with BEST. Clinical and radiological assessments were used to evaluate the treatment response, categorized as "significantly reduced", "reduced", "stable disease", or "lesion growth". Postprocedural complications and functional outcomes were systematically recorded. <b>Results:</b> A total of 29 BEST sessions were performed. Lesions of the tongue (<i>n</i> = 8) and combined oral cavity and tongue (<i>n</i> = 6) showed the highest response rates, with significant symptom reduction in five out of eight and five out of six patients, respectively. Among isolated oral cavity lesions (<i>n</i> = 4), one out of four demonstrated a significant reduction. In contrast, laryngeal and hypopharyngeal lesions (<i>n</i> = 2) had limited response, with one case showing partial reduction and the other remaining stable. Severe complications, including bleeding and dyspnea requiring tracheostomy, limited further treatment in these locations. No systemic adverse events, such as pulmonary toxicity, were observed. <b>Conclusions:</b> BEST is effective for treating vascular malformations of the upper aerodigestive tract, particularly in the tongue and oral cavity, but presents significant risks in laryngeal and hypopharyngeal lesions. A multidisciplinary approach is required to optimize treatment protocols for these challenging locations.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2025-04-27
DOI
https://doi.org/10.3390/biomedicines13051055
Citations
4
Primary Topic
Aerosol Filtration and Electrostatic Precipitation
Type
article
Field-Weighted Citation Impact
2.92

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bleomycin Electrosclerotherapy (BEST) for Slow-Flow Malformations of the Upper Aerodigestive Tract

Veronika Vielsmeier, Christopher Bohr, Florian Obereisenbuchner, Vanessa F. Schmidt et al.
4 citations
Biomedicines
Aerosol Filtration and Electrostatic Precipitation
2.92
article

Bleomycin Electrosclerotherapy (BEST) for Slow-Flow Malformations of the Upper Aerodigestive Tract

Veronika Vielsmeier, Christopher Bohr, Florian Obereisenbuchner, Vanessa F. Schmidt, Natascha Platz Batista da Silva, Jens Ricke, Moritz Wildgruber, Daniel Puhr‐Westerheide, Max Seidensticker, Walter Alexander Wohlgemuth, Thomas Kühnel, Caroline Theresa Seebauer
article en
4 citations

Abstract

<b>Background/Objectives:</b> Bleomycin electrosclerotherapy (BEST), which combines intralesional bleomycin administration with electroporation, enhances drug uptake and has shown efficacy in treating vascular malformations resistant to conventional therapies. While BEST is increasingly used in various anatomical sites, its application in the upper aerodigestive tract remains underexplored. This study evaluates the safety and effectiveness of BEST in managing slow-flow vascular malformations of the oral cavity, tongue, larynx, and hypopharynx. <b>Methods:</b> In this retrospective, multicenter study, 20 patients with symptomatic slow-flow vascular malformations of the upper aerodigestive tract were treated with BEST. Clinical and radiological assessments were used to evaluate the treatment response, categorized as "significantly reduced", "reduced", "stable disease", or "lesion growth". Postprocedural complications and functional outcomes were systematically recorded. <b>Results:</b> A total of 29 BEST sessions were performed. Lesions of the tongue (<i>n</i> = 8) and combined oral cavity and tongue (<i>n</i> = 6) showed the highest response rates, with significant symptom reduction in five out of eight and five out of six patients, respectively. Among isolated oral cavity lesions (<i>n</i> = 4), one out of four demonstrated a significant reduction. In contrast, laryngeal and hypopharyngeal lesions (<i>n</i> = 2) had limited response, with one case showing partial reduction and the other remaining stable. Severe complications, including bleeding and dyspnea requiring tracheostomy, limited further treatment in these locations. No systemic adverse events, such as pulmonary toxicity, were observed. <b>Conclusions:</b> BEST is effective for treating vascular malformations of the upper aerodigestive tract, particularly in the tongue and oral cavity, but presents significant risks in laryngeal and hypopharyngeal lesions. A multidisciplinary approach is required to optimize treatment protocols for these challenging locations.

BiomedicinesVol. 13(5)
LMU Klinikum (DE), Luzerner Kantonsspital (CH), University Hospital in Halle (DE), Ludwig-Maximilians-Universität München (DE)
Universitätsklinikum Regensburg
Good health and well-being
Openalex Percentile: Top 9%
Aerosol Filtration and Electrostatic Precipitation
2.92
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.